Compare G & RDNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | G | RDNT |
|---|---|---|
| Founded | 1997 | 1985 |
| Country | Bermuda | United States |
| Employees | 140000 | N/A |
| Industry | Professional Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 4.6B |
| IPO Year | 2007 | 1996 |
| Metric | G | RDNT |
|---|---|---|
| Price | $28.28 | $56.20 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $49.50 | ★ $82.80 |
| AVG Volume (30 Days) | ★ 2.7M | 827.9K |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | ★ 2.21% | N/A |
| EPS Growth | ★ 9.82 | N/A |
| EPS | ★ 0.86 | N/A |
| Revenue | ★ $2,279,438,000.00 | $1,616,630,000.00 |
| Revenue This Year | $9.20 | $22.78 |
| Revenue Next Year | $7.27 | $10.70 |
| P/E Ratio | $32.69 | ★ N/A |
| Revenue Growth | N/A | ★ 13.05 |
| 52 Week Low | $27.37 | $50.79 |
| 52 Week High | $48.64 | $85.84 |
| Indicator | G | RDNT |
|---|---|---|
| Relative Strength Index (RSI) | 31.84 | 52.74 |
| Support Level | N/A | $55.11 |
| Resistance Level | $35.09 | $64.38 |
| Average True Range (ATR) | 1.08 | 2.76 |
| MACD | -0.39 | 0.12 |
| Stochastic Oscillator | 17.15 | 60.21 |
Genpact Ltd is an agentic, technology-solutions company offering digital transformation, data-driven operations, and technology-enabled services across multiple industries. Its core business services include decision support services; technology services like application lifecycle management, platform customization, and support, etc; and digital operations optimizing business processes. Genpact also offers data engineering, data management, and domain-based AI and generative AI solutions; develops new technology solutions for clients; and offers agentic solutions and technology consulting services. Its reportable segments are: High Tech and Manufacturing, which generate maximum revenue, Financial Services, and Consumer and Healthcare. Geographically, it derives maximum revenue from India.
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.